Eledon Pharmaceuticals, Inc. Payments of Stock Issuance Costs
Eledon Pharmaceuticals, Inc. (ELDN) reported Payments of Stock Issuance Costs of $450.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-03-30
- Eledon Pharmaceuticals, Inc. payments of stock issuance costs for the quarter ending 2021-12-31 was $0.00.
- Eledon Pharmaceuticals, Inc. payments of stock issuance costs for the quarter ending 2021-09-30 was $0.00.
- Eledon Pharmaceuticals, Inc. payments of stock issuance costs for the quarter ending 2021-06-30 was $0.00.
- Eledon Pharmaceuticals, Inc. payments of stock issuance costs for the quarter ending 2021-03-31 was $450.00K.
- Eledon Pharmaceuticals, Inc. payments of stock issuance costs for fiscal 2021 was $450.00K.
- Eledon Pharmaceuticals, Inc. payments of stock issuance costs for fiscal 2014 was $3.30M, a 10913.33% increase from fiscal 2013.
- Eledon Pharmaceuticals, Inc. payments of stock issuance costs for fiscal 2013 was $30.00K.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 9 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $0.00 derived: sum of 3 quarters · filed 2023-03-30 | $450.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $450.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $450.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $450.00K 10-Q · filed 2022-05-12 | |||
| 2014-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $2.83M derived: sum of 2 quarters · filed 2017-03-03 | $3.30M 10-K · filed 2017-03-03 | |
| 2014-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $1.97M 10-Q · filed 2015-11-10 | ||
| 2014-06-30 | $479.00K 10-Q · filed 2015-08-12 | |||
| 2013-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $30.00K 10-K · filed 2016-03-10 | ||
| 2013-09-30 | $10.00K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |